New studies link GLP-1 drugs like Ozempic and Mounjaro to lower cancer progression and death risk, including breast cancer benefits—learn what the data...
May 22, 2026, 6:47 AM ETNovo Nordisk A/S (NVO) Stock, LLY StockBy : Arundhati Sarkar, SA News Editor
Comments
(8)
The world’s most popular weight-loss and diabetes drugs are linked to a powerful new possible benefit: better outcomes for cancer patien... [266 chars]